Thursday, June 01, 2023
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



Sputnik Light, AstraZeneca vaccines with high immunity after trials

Sputnik Light, AstraZeneca vaccines with high immunity after trials

Moscow, Aug 20 (Prensa Latina) A combination of Sputnik Light and AstraZeneca Covid-19 vaccines has proven high immunity in volunteers during the clinical trials in Azerbaijan, the Russian Direct Investment Fund (RDIF) stated on Friday.

According to the report on the results of those trials, 100 percent of the 20 participants have shown antibodies to the SARS-CoV-2 virus spike protein (S-protein).

Trials in Azerbaijan began in February 2021 and to date, 64 volunteers have been vaccinated with the combined vaccine candidate.

Earlier trials also showed high safety indicators for the combined use of Sputnik Light, developed by Russia, and AstraZeneca, co-developed at the University of Oxford, in the United Kingdom.

No serious side effects or cases of coronavirus contagion after vaccination have been reported, the RDIF stated.

A clinical trial of the combination of vaccines is currently being implemented in several countries, as part of a global program, among them the United Arab Emirates and Argentina, and a regulatory approval to conduct trials has been granted in Russia and Belarus.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.